Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00270829 · ClinicalTrials.gov registry record · Phase 4
Renal Effects of Intrarenal Nesiritide
A Phase 4 study, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT00270829: Clinical Trial Phase 4 study, sponsored by University of Maryland, Baltimore.
NCT00270829 is a Phase 4 study that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 2 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00270829, a Phase 4 study, was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
The impact of nesiritide in CHF is unclear, but it is possible that systemic vasodilation leads to adverse consequences even if the direct renal effects are positive. Therefore, this study will look at the effects of direct intrarenal administration of nesiritide on GFR and RPF.
Interventions
- DRUG nesiritide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2005-12 |
| Est. Completion | 2007-01 |
| Phase | Phase 4 |
Why NCT00270829 stopped before completion
NCT00270829 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which nesiritide is the first listed.
NCT00270829 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00270829 about?
NCT00270829 is a clinical study titled "Renal Effects of Intrarenal Nesiritide". The impact of nesiritide in CHF is unclear, but it is possible that systemic vasodilation leads to adverse consequences even if the direct renal effects are positive. Therefore, this study will look at the effects of direct intrarenal administration of nesiritide on GFR and RPF.
What is the current status of trial NCT00270829?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2005-12. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00270829?
The interventions under investigation include: nesiritide (DRUG).
Who is sponsoring clinical trial NCT00270829?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00270829's enrollment target sits among peer trials
2 1998th of 2000 higher than 1 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia